| Summary Information |
| Diseases
/
List of Parasitic Diseases
/ Disease summary |
| Alternative Names |
--
See also:
|
| Disease Agents |
-
Specifically recorded for Elephas maximus
- Asian Elephant:
- Fasciola hepatica (B24,
B64.27.w4,
B214.3.7.w3)
- Fasciola jacksoni (B24,
J1.14.w6, B212.w33,
B214.3.7.w3, B455.w7,
J350.10.w1,
J379.3.w1, J379.5.w1,
J387.16.w1)
Found in Burma and India, in the bile ducts and duodenum. Adults 12 -
14 mm long, 9.0 - 12.5 mm wide and central thickness 1.5 - 2.0 mm. (J379.3.w1,
J379.5.w1)
- Synonyms Cladocoelium elephantis Diesing, 1958; Distomum
elephantis Diesing, 1858; Distomum jacksoni Braun,
1892; Distomum jacksonii Braun, 1892; Fasciolopsis
jacksoni Looss, 1899. (J379.3.w1)
-
Specifically recorded for Loxodonta africana
- African Elephant:
-
Fasciola robustum (B64.27.w4,
B214.3.7.w3)
Further information on Disease Agents has only been
incorporated for agents recorded in species for which a full Wildpro "Health
and Management" module has been completed (i.e. for which a comprehensive literature
review has been undertaken). Only those agents with further information available are
linked below:
|
| Infectious
Agent(s) |
Fasciola spp. (Fasciolidae - (Family))
|
| Non-infectious
Agent(s) |
-- |
| Physical
Agent(s) |
--
|
| General
Description |
In Elephants:
- Fasciola hepatica occurs in elephants. (B24)
Elephas maximus
- Asian Elephant:
-
Fasciola jacksoni infection was reported in a group of
captive elephants in Malaysia. (J1.14.w6)
-
Wild elephants in Assam, India, had an overall prevalence rate of
33.78%, while in captive elephants prevalence rates varied between
locations: 42.50%, 62.28% and 18.18%. (J380.11.w1)
-
Found in two captive elephants at Kaziranga National Park, Assam,
India. Intestinal amphistomes were also present. See: Intestinal Fluke Infection in Elephants
(J380.13.w1)
Loxodonta africana
- African Elephant:
Clinical signs:
- Anorexia and associated weight loss. (B212.w33,
B455.w7, J1.14.w6,
J380.11.w1)
- Pale mucous membranes (B212.w33,
B455.w7, J1.14.w6)
or jaundice.
(B212.w33, B455.w7,
J380.11.w1)
- Colic. (B64.27.w4,
B336.53.w53)
- Diarrhoea
(B64.27.w4, B212.w33,
B336.53.w53)
or constipation.
(B336.53.w53)
- Sometimes "depraved appetite". (J1.14.w6);
earth may be eaten. (B212.w33)
- Depression and debility. (B212.w33,
B455.w7)
(B64.27.w4, B212.w33,
B455.w7, B336.53.w53,
J1.14.w6, J380.11.w1)
- Loss of weight, "depraved appetite", submandibular oedema,
ventral abdominal oedema, and pale mucous membranes.
(J1.14.w6)
- Anaemia and hypoproteinaemia were found, with severe anaemia in the
most severely (fatally) affected elephant. (J1.14.w6)
- Anorexia, constipation, malodorous faeces, dehydration, anaemia and jaundice
were noted in elephants, particularly young elephants, in Assam,
India. (J380.11.w1)
- Some adult elephants did not show any obvious clinical signs. (J380.11.w1)
- With chronic disease, hypoproteinaemia occurs due to hyperplastic
cholangitis allowing plasma protein leakage. (B455.w7)
- Depression, variable appetite, frequent yawning, thirst, pale or yellowish mucous
membranes, sometimes puffiness around the head and shoulders, dry,
scurfy skin indicating general unthriftiness, sometimes eating of
earth, severe
and sometimes persistent dark, foul-smelling diarrhoea containing
flukes, debility, weight loss, oedema, extreme exhaustion and death. (B212.w33)
Mortality:
- Mortality can be high. (J350.10.w1)
- Death occurred some in elephants with severe clinical signs in
Assam, India. (J380.11.w1)
- Severe disease can be fatal. (B212.w33)
Susceptibility:
- In Assam, India, young elephants were most affected, with clinical
disease, sometimes fatal, while some old adults showed no apparent
clinical signs. (J380.11.w1)
|
| Further Information |
Pathology:
- In elephants dying with severe infection (although flukes were not
proven to be the cause of death), cystic and larval forms were found
in large numbers in the liver, lungs and intestines. (B212.w33)
- Hepatic:
- Flukes in the bile ducts. (B212.w33)
- Numerous trematodes in the bile ducts; this may cause bile stone
formation (see Cholelithiasis in Elephants). (B64.27.w4,
J1.14.w6)
- Massive liver damage was noted in some elephants in Assam, India. (J380.11.w1)
- Bile ducts packed with massive numbers of flukes and exudate.
Liver hard and fibrosed. (J387.16.w1)
- Cardiac: In one elephant in India, an embolus was found in a
superficial epicardial vessel. Immature parasites were found in a
pericardial vessel. (J380.11.w1)
Histopathology:
- Hepatic: Excessive fibrous tissue proliferation causing focal
periportal cirrhosis and pseudolobulation, with a mild infiltration of
mononuclear cells. (J387.16.w1)
- Bile ducts: epithelial surface covered in a "necrotic
homogenous mass admixed with erythrocytes and eggs of the parasites."
(J387.16.w1)
Diagnosis/Investigations:
- Haematology and biochemistry before treatment revealed anaemia and
hypoproteinaemia, respectively. (J1.14.w6)
- Faecal flotation to detect eggs. (B455.w7)
- Faeces were examined for trematode eggs by a zinc sulphate flotation
technique, followed by identification. (B64.27.w4,
B336.53.w53,
J1.14.w6)
- Trematode eggs, 60 - 72 x 108 - 132 µm, at six to 83 eggs per
gram faeces, were found. (J1.14.w6)
- Note: Faecal egg counts may be affected by the time of
day at which faeces are collected. A study in India recorded average counts
(eggs per gram) of 4.89 (morning), 2.47 (noon) and 2.76 (evening), respectively.
(J380.11.w1)
- The bromsulphalein (sulphobromophthalein, BSP) clearance test may be used to detect
liver damage associated with the parasites. (B450.5.w5,
J1.14.w6)
- BSP clearance rates varied from 3.6 - 6.5 minutes (half-time)
and were noted to be slower in two elephants (5.1 and 6.5 mins) than in two
others (3.6 and 4.3 mins). One of those with slow BSP clearance had clinical signs
including submandibular oedema. The normal BSP clearance time for
elephants is not known. (J1.14.w6)
- In elephants dying with severe infection (although flukes were not
proven to be the cause of death), cystic and larval forms were found
in large numbers in the liver, lungs and intestines. (B212.w33)
Treatment:
- Trichoromehylbenzol. (B64.27.w4)
- Nitroxynil 10mg/kg by subcutaneous injection. There was a local
reaction at the injection site in seven of the nine animals treated.
No systemic reaction was recorded. (J1.14.w6)
- Triclabendazole (9 mg/kg, not exceeding 7200 mg/animal) was found to
be 100% effective in treatment of elephants in Assam, India. (J380.11.w1)
- Oxyclozanide (7.5 mg/kg, not exceeding 6.8 g/animal) was found to be
72.16% effective in treatment of elephants in Assam, India. (J380.11.w1)
- Chlorsulon at 7 mg/kg body weight orally, two doses at an interval
of 45 to 60 days. (B455.w7)
- Albendazole is effective. (B455.w7)
Prevention/Control:
- Faecal examination for parasites should be performed at least once a
year. More frequent examinations are recommended in endemic areas. (B450.5.w5)
- Avoid grazing elephants on wet, marshy ground. (B212.w33,
J350.10.w1)
|
| Associated Techniques |
|
| Host taxa groups /species |
Further information on Host species has only
been incorporated for species groups for which a full Wildpro "Health and
Management" module has been completed (i.e. for which a comprehensive literature
review has been undertaken).
(List does not contain all other species groups affected by this
disease)
|